SEC Form 4 · accession 0001209191-18-057614
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim D Blickenstaff
Officer — PRESIDENT & CEO · Director
Period of report
Nov 6, 2018
Accepted (ET)
Nov 7, 2018 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 6, 2018 | S | 19,270 | $37.00 | D | 1,370,480 | I | See Footnotes |
| Common StockF2,F1 | Nov 7, 2018 | S | 178,730 | $37.0091 | D | 1,191,750 | I | See Footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held by the Kim Blickenstaff Revocable Trust.
- F2The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.00 and $37.205.